Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Amivantamab Monotherapy in Chemorefractory RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Results From OrigAMI-1, an Open-Label, Phase Ib/II Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 21, 2026
Pasritamig, a First-in-Class, Bispecific T-Cell Engager Targeting Human Kallikrein 2, in Metastatic Castration-Resistant Prostate Cancer: A Phase I Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 01, 2025
Intracranial and systemic progression on amivantamab in platinum-treated epidermal growth factor receptor exon 20 insertion-mutated advanced non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: January 21, 2025
Amivantamab in Participants With Advanced NSCLC and MET Exon 14 Skipping Mutations: Final Results From the CHRYSALIS Study.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: December 18, 2024
Amivantamab in Participants With Advanced NSCLC and MET Exon 14 Skipping Mutations: Final Results From the CHRYSALIS Study.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: December 18, 2024
The LIN28B-let-7-PBK pathway is essential for group 3 medulloblastoma tumor growth and survival.
Journal: Molecular oncology
Published: February 03, 2023
Identification and targeting of protein tyrosine kinase 7 (PTK7) as an immunotherapy candidate for neuroblastoma.
Journal: Cell reports. Medicine
Published: September 16, 2022
RNA Binding Protein LIN28B: a prime time player shaping neuroblastoma aggression and metastasis.
Journal: Oncoscience
Published: May 14, 2020
LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinase.
Journal: Neoplasia (New York, N.Y.)
Published: January 27, 2020
YAP-Mediated Repression of HRK Regulates Tumor Growth, Therapy Response, and Survival Under Tumor Environmental Stress in Neuroblastoma.
Journal: Cancer research
Published: January 06, 2020
Limited antitumor activity of combined BET and MEK inhibition in neuroblastoma.
Journal: Pediatric blood & cancer
Published: January 03, 2020
Last Updated: 09/26/2026